OneDose says eMACC topped 10,000 critical medication scans

OneDose says its eMACC medication cross-check has surpassed 10,000 critical scans since launching in December 2025, with most scans starting inside the protocol workflow. The milestone underscores growing use of software-based medication verification in EMS, including by solo providers who previously lacked a full audit trail.

Why it matters: - OneDose is positioning eMACC as a way to bring the Medication Administration Cross-Check into routine EMS practice, including for solo providers. - The company says the system creates a permanent audit trail, which could help close a longstanding measurement gap in medication safety.

What happened: - OneDose said eMACC, the electronic Medication Administration Cross-Check built into the OneDose protocol app platform, has surpassed 10,000 critical medication scans since its December 2025 launch. - The milestone marks the first time the Medication Administration Cross-Check has been available to solo providers with a complete audit trail. - Platform analytics show about 21 agencies adopt eMACC every week. - Monthly scan volume roughly doubled between February and May 2026.

The details: - The Medication Administration Cross-Check, developed by Dr. Paul Misasi, is widely used across EMS agencies in the U.S. - In the peer-reviewed study behind the cross-check, the method reduced observed medication error by 49% overall and by 71.1% for fentanyl. - eMACC implements the MACC cognitive sequence in software. - A single provider scans the vial, the system verifies medication identity and concentration, links it to the protocol-specific dose, guides syringe selection and preparation, and records the sequence automatically. - For two-provider crews, eMACC structures and captures the cross-check. - For solo medics, eMACC provides a verification sequence the verbal MACC cannot. - Fentanyl is among the most frequently scanned medications in eMACC. - Platform analytics show more than 10,000 eMACC critical scans across participating agencies. - Platform analytics also show 83% of scans were initiated from within the protocol workflow, suggesting routine clinical use rather than standalone lookups. - A permanent, exportable audit record was created for every scan.

Between the lines: - The field data suggests clinicians kept using eMACC after initial rollout, which matters for any safety tool that depends on sustained adoption. - OneDose is also trying to solve a known EMS reporting problem: retrospective incident reporting tends to miss many safety events. - One published EMS series reported 17 medication errors per 10,000 administrations across 34,531 administrations, based on compulsory post-incident self-reporting. - A separate systematic review found structured record review identified 9.9 safety incidents per 100 encounters, while incident reporting captured only 0.3 per 100, a 33-fold gap. - OneDose says eMACC generates structured data at the moment of verification instead of relying on retrospective reporting. - The company frames eMACC as one layer in a broader medication safety system that also includes a protocol platform, dosing engine, AI assistant and OneWeight stretcher-integrated scale. - In an IRB-approved validation study of 50 adults at the University of Nebraska Medical Center, OneWeight measured within 10% of a certified standing scale for 100% of subjects and within 5% for 98%. - Published research indicates paramedic visual weight estimates fall within 10% of actual weight less than half the time. - A 2026 internal dose audit at a Midwest municipal EMS agency found medication administration volume rose 52% from 2023 to 2025 while dose-error rate fell 53% overall and about 72% on a like-for-like medication set excluding acetaminophen. - That audit was observational, single-agency and not peer-reviewed. - The company notes the 49% and 71.1% error-reduction figures come from studies of the two-provider verbal MACC, not eMACC itself. - OneDose says the eMACC syringe emulator has not yet been independently studied.

What's next: - OneDose says participating agencies now have quantitative visibility into medication verification activity that was previously unavailable. - The company is steering readers to more information on the eMACC product page and OneDose's main site.

The bottom line: - OneDose is turning a proven EMS cross-check into software meant to work on every call, including solo-response situations where a verbal second check is not possible.